GENEVA, Sept. 24 -- DANA-FARBER CANCER INSTITUTE, INC. filed a patent application (IB2026/052580) for “METHODS OF IMAGING AND TREATING CANCERS HAVING ABERRANT EXPRESSION OF EGFR”. With publication no. WO/2026/196173, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 51/10
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....